New York Life Investment Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
New York Life Investment Management's ZBH Position: Q2 2026 in Review
New York Life Investment Management reduced its Zimmer Biomet (ZBH) stake by 1.9% in Q2 2026, selling an estimated $50.2K and leaving 28,867 shares worth $2.49M. The position accounts for 0.02% of the portfolio, ranked #521.
New York Life Investment Management first reported a position in ZBH in Q2 2022 and has held it in 17 quarters since. The position peaked at $4.77M in Q2 2023. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- New York Life Investment Management held 28,867 shares of Zimmer Biomet worth $2.49M as of Q2 2026.
- New York Life Investment Management sold 573 Zimmer Biomet shares in Q2 2026, an estimated $50.2K.
- Zimmer Biomet made up 0.02% of New York Life Investment Management's portfolio in Q2 2026, its #521 holding.
- New York Life Investment Management first reported a position in Zimmer Biomet in Q2 2022 and has held it in 17 quarters since.
- New York Life Investment Management's Zimmer Biomet position peaked at $4.77M in Q2 2023.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.